Amortization of Intangible Assets of AXIM BIOTECHNOLOGIES, INC. from 31 Mar 2011 to 30 Jun 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary: AXIM BIOTECHNOLOGIES, INC. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 31 Mar 2011 to 30 Jun 2024.
AXIM BIOTECHNOLOGIES, INC. Amortization of Intangible Assets for the quarter ending 30 Jun 2024 was $98,612, unchanged year-over-year.
AXIM BIOTECHNOLOGIES, INC. annual Amortization of Intangible Assets for 2023 was $394,446, unchanged from 2022.
AXIM BIOTECHNOLOGIES, INC. annual Amortization of Intangible Assets for 2022 was $394,446, a 81% decline from 2021.
AXIM BIOTECHNOLOGIES, INC. annual Amortization of Intangible Assets for 2021 was $2,087,908.
Source SEC data: View on sec.gov

Amortization of Intangible Assets, Trailing 12 Months (USD)

Amortization of Intangible Assets, Quarterly (USD)

Amortization of Intangible Assets, YoY Quarterly Change (%)

Amortization of Intangible Assets, Annual (USD)

Amortization of Intangible Assets, YoY Annual Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Amortization of Intangible Assets (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2024		$98,612	$0	0%	01 Apr 2024	30 Jun 2024	10-Q	19 Aug 2024	2024	Q2
Q1 2024		$98,612	$0	0%	01 Jan 2024	31 Mar 2024	10-Q/A	22 May 2024	2024	Q1
Q2 2023	$394,447	$98,612	$0	0%	01 Apr 2023	30 Jun 2023	10-Q	19 Aug 2024	2024	Q2
Q1 2023	$394,447	$98,612	+$1	+0%	01 Jan 2023	31 Mar 2023	10-Q/A	22 May 2024	2024	Q1
Q4 2022	$394,446	$98,611	-$655,343	-87%	01 Oct 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
Q3 2022	$1,049,789	$98,612	-$594,246	-86%	12 Jul 2022	30 Sep 2022	10-Q/A	15 Nov 2022	2022	Q3
Q2 2022	$1,644,035	$98,612	-$542,484	-85%	01 Apr 2022	30 Jun 2022	10-Q	16 Aug 2022	2022	Q2
Q1 2022	$2,186,519	$98,611	+$98,611		01 Jan 2022	31 Mar 2022	10-Q	22 May 2023	2023	Q1
Q4 2021	$2,087,908	$753,954			01 Oct 2021	31 Dec 2021	10-K	17 Apr 2023	2022	FY
Q3 2021		$692,858			01 Jul 2021	30 Sep 2021	10-Q/A	15 Nov 2022	2022	Q3
Q2 2021		$641,096			01 Apr 2021	30 Jun 2021	10-Q	16 Aug 2022	2022	Q2
Q1 2021		$0	-$3,637	-100%	01 Jan 2021	31 Mar 2021	10-Q	23 May 2022	2022	Q1
Q1 2020		$3,637	+$479	+15%	01 Jan 2020	31 Mar 2020	10-Q/A	02 Jul 2020	2020	Q1
Q1 2019		$3,158	-$6,318	-67%	01 Jan 2019	31 Mar 2019	10-Q/A	02 Jul 2020	2020	Q1
Q1 2018		$9,476	+$9,476		01 Jan 2018	31 Mar 2018	10-Q	15 May 2019	2019	Q1
Q1 2017		$0			01 Jan 2017	31 Mar 2017	10-Q/A	18 May 2018	2018	Q1
Q1 2014		$1,593	-$907	-36%	01 Jan 2014	31 Mar 2014	10-Q/A	18 Jun 2014	2014	Q1
Q1 2013		$2,500	+$1,250	+100%	01 Jan 2013	31 Mar 2013	10-Q/A	18 Jun 2014	2014	Q1
Q1 2012		$1,250	+$1,250		01 Jan 2012	31 Mar 2012	10-Q	15 May 2013	2013	Q1
Q1 2011		$0			01 Jan 2011	31 Mar 2011	10-Q	17 May 2012	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$394,446	$0	0%	01 Jan 2023	31 Dec 2023	10-K	16 Apr 2024	2023	FY
2022	$394,446	-$1,693,462	-81%	01 Jan 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
2021	$2,087,908	+$2,087,908		01 Jan 2021	31 Dec 2021	10-K	17 Apr 2023	2022	FY
2020	$0	-$3,158	-100%	01 Jan 2020	31 Dec 2020	10-K/A	19 Apr 2022	2021	FY
2019	$3,158	-$6,317	-67%	01 Jan 2019	31 Dec 2019	10-K/A	20 May 2020	2019	FY
2018	$9,475	+$9,475		01 Jan 2018	31 Dec 2018	10-K/A	20 May 2020	2019	FY
2017	$0			01 Jan 2017	31 Dec 2017	10-K	08 Apr 2019	2018	FY
2013	$10,000	+$4,528	+83%	01 Jan 2013	31 Dec 2013	10-K	04 Mar 2014	2013	FY
2012	$5,472	+$4,640	+558%	01 Jan 2012	31 Dec 2012	10-K	04 Mar 2014	2013	FY
2011	$832			01 Jan 2011	31 Dec 2011	10-K	15 Apr 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.